You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 11, November 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

X-linked Dyskeratosis Congenita With Pancytopenia

Aron Gutman, MD; Azriel Frumkin, MD; Avinoam Adam, PhD; Nava Bloch-Shtacher, PhD; Leon A. Rozenszajn, PhD

Arch Dermatol. 1978;114(11):1667-1671.


Abstract

• Two maternal male cousins in a Jewish Iraqi kindred were affected with dyskeratosis congenita and had a megaloblastic bone marrow. One cousin had pancytopenia and the other had thrombocytopenia. The kindred displays a deficiency of glucose-6-phosphate dehydrogenase (G6PD) and a β-thalassemia trait. The following genetic "markers" of the X chromosome were studied: G6PD, the X-linked blood groups Xg, and color vision. Linkage analysis indicated that dyskeratosis, G6PD, and Xg are far apart on the X chromosome. Chromosomal studies showed a 46XY karyotype in both cases; however, nonspecific numerical aberrations and structural abnormalities were found in the first and in the second case, polyploidy was seen in four of 60 cells. The proband's cultured fibroblasts did not show increased susceptibility to malignant transformation by simian virus 40, an oncogenic virus.

(Arch Dermatol 114:1667-1671, 1978)



Author Affiliations

From the Department of Internal Medicine C (Dr Gutman) and the Hematological Laboratories (Dr Rozenszajn), Meir Hospital, Kfar-Saba, Israel; the Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel (Dr Rozenszajn); and the Department of Human Genetics, Sackler School of Medicine, Tel Aviv, Israel (Drs Adam and Bloch-Shtacher). Dr Frumkin is now with Kaplan Hospital, Rehovoth, Israel.


Footnotes

Accepted for publication May 1, 1978.

Deceased.

Reprint requests to Department of Internal Medicine C, Meir Hospital, Kfar-Saba, Israel (Dr Gutman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dyskeratosis Congenita: Multisystemic Disorder with Special Consideration of Immunologic Aspects: A Review of the Literature
Solder et al.
CLIN PEDIATR 1998;37:521-530.
ABSTRACT  

Dyskeratosis Congenita in a Girl Simulating Chronic Graft-vs-Host Disease
Ling et al.
Arch Dermatol 1985;121:1424-1428.
ABSTRACT  

Dyskeratosis Congenita With Macular Cutaneous Amyloid Deposits
Llistosella et al.
Arch Dermatol 1984;120:1381-1382.
ABSTRACT  

Fanconi's Anemia: Tumor-like Warts, Hyperpigmentation Associated With Deranged Keratinocytes, and Depressed Cell-Mediated Immunity
Johansson et al.
Arch Dermatol 1982;118:249-252.
ABSTRACT  

Intracranial Calcifications and Dyskeratosis Congenita
Mills et al.
Arch Dermatol 1979;115:1437-1439.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.